nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1D—meninx—brain cancer	0.0438	0.0684	CbGeAlD
Methysergide—HTR1F—trigeminal nerve—brain cancer	0.0437	0.0682	CbGeAlD
Methysergide—HTR1B—dura mater—brain cancer	0.0416	0.065	CbGeAlD
Methysergide—HTR1D—dura mater—brain cancer	0.0403	0.0629	CbGeAlD
Methysergide—HTR2C—choroid plexus—brain cancer	0.0339	0.053	CbGeAlD
Methysergide—HTR1B—trigeminal nerve—brain cancer	0.0179	0.0279	CbGeAlD
Methysergide—HTR1D—trigeminal nerve—brain cancer	0.0173	0.0271	CbGeAlD
Methysergide—HTR2A—choroid plexus—brain cancer	0.017	0.0266	CbGeAlD
Methysergide—HTR1F—ganglion—brain cancer	0.0157	0.0246	CbGeAlD
Methysergide—Leg edema—Temozolomide—brain cancer	0.0148	0.0462	CcSEcCtD
Methysergide—HTR1B—cranial nerve—brain cancer	0.0127	0.0199	CbGeAlD
Methysergide—HTR7—vein—brain cancer	0.0125	0.0195	CbGeAlD
Methysergide—HTR1D—cranial nerve—brain cancer	0.0123	0.0193	CbGeAlD
Methysergide—HTR6—ganglion—brain cancer	0.0107	0.0167	CbGeAlD
Methysergide—HTR1B—telencephalic ventricle—brain cancer	0.0104	0.0162	CbGeAlD
Methysergide—HTR1D—telencephalic ventricle—brain cancer	0.01	0.0157	CbGeAlD
Methysergide—HTR2C—telencephalic ventricle—brain cancer	0.00993	0.0155	CbGeAlD
Methysergide—HTR7—cranial nerve—brain cancer	0.00983	0.0154	CbGeAlD
Methysergide—HTR7—pons—brain cancer	0.00971	0.0152	CbGeAlD
Methysergide—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00866	0.0271	CcSEcCtD
Methysergide—HTR2A—trigeminal nerve—brain cancer	0.0086	0.0134	CbGeAlD
Methysergide—Pleural effusion—Procarbazine—brain cancer	0.00859	0.0269	CcSEcCtD
Methysergide—HTR2A—cerebellar cortex—brain cancer	0.00857	0.0134	CbGeAlD
Methysergide—HTR1A—telencephalic ventricle—brain cancer	0.00836	0.0131	CbGeAlD
Methysergide—HTR7—telencephalic ventricle—brain cancer	0.00799	0.0125	CbGeAlD
Methysergide—HTR2A—vein—brain cancer	0.00777	0.0121	CbGeAlD
Methysergide—Ataxia—Lomustine—brain cancer	0.00708	0.0221	CcSEcCtD
Methysergide—HTR1B—ganglion—brain cancer	0.00645	0.0101	CbGeAlD
Methysergide—HTR1D—ganglion—brain cancer	0.00625	0.00976	CbGeAlD
Methysergide—HTR2C—ganglion—brain cancer	0.00618	0.00966	CbGeAlD
Methysergide—HTR2A—cranial nerve—brain cancer	0.00613	0.00958	CbGeAlD
Methysergide—HTR1F—telencephalon—brain cancer	0.00607	0.00949	CbGeAlD
Methysergide—HTR2A—pons—brain cancer	0.00606	0.00946	CbGeAlD
Methysergide—HTR1E—brainstem—brain cancer	0.00593	0.00926	CbGeAlD
Methysergide—HTR1E—telencephalon—brain cancer	0.00526	0.00822	CbGeAlD
Methysergide—HTR1A—ganglion—brain cancer	0.00521	0.00813	CbGeAlD
Methysergide—HTR1B—blood vessel—brain cancer	0.00513	0.00801	CbGeAlD
Methysergide—Hyperaesthesia—Temozolomide—brain cancer	0.00507	0.0158	CcSEcCtD
Methysergide—HTR2A—telencephalic ventricle—brain cancer	0.00498	0.00779	CbGeAlD
Methysergide—HTR7—ganglion—brain cancer	0.00497	0.00777	CbGeAlD
Methysergide—HTR1D—blood vessel—brain cancer	0.00497	0.00776	CbGeAlD
Methysergide—Blood urea increased—Hydroxyurea—brain cancer	0.00481	0.015	CcSEcCtD
Methysergide—Alopecia—Lomustine—brain cancer	0.0046	0.0144	CcSEcCtD
Methysergide—Ataxia—Procarbazine—brain cancer	0.00449	0.014	CcSEcCtD
Methysergide—HTR2A—pineal body—brain cancer	0.00432	0.00675	CbGeAlD
Methysergide—HTR7—endothelium—brain cancer	0.00429	0.0067	CbGeAlD
Methysergide—HTR6—telencephalon—brain cancer	0.00413	0.00645	CbGeAlD
Methysergide—Eosinophilia—Procarbazine—brain cancer	0.00409	0.0128	CcSEcCtD
Methysergide—HTR7—blood vessel—brain cancer	0.00396	0.00618	CbGeAlD
Methysergide—HTR1A—hindbrain—brain cancer	0.00395	0.00617	CbGeAlD
Methysergide—HTR1F—head—brain cancer	0.00378	0.00591	CbGeAlD
Methysergide—HTR7—hindbrain—brain cancer	0.00377	0.00589	CbGeAlD
Methysergide—Drowsiness—Procarbazine—brain cancer	0.00368	0.0115	CcSEcCtD
Methysergide—Thrombocytopenia—Lomustine—brain cancer	0.00362	0.0113	CcSEcCtD
Methysergide—Pain—Carboplatin—brain cancer	0.00361	0.0113	CcSEcCtD
Methysergide—Thrombophlebitis—Carmustine—brain cancer	0.00345	0.0108	CcSEcCtD
Methysergide—HTR1F—central nervous system—brain cancer	0.00345	0.00539	CbGeAlD
Methysergide—Body temperature increased—Carboplatin—brain cancer	0.00334	0.0104	CcSEcCtD
Methysergide—Thrombophlebitis—Temozolomide—brain cancer	0.00334	0.0104	CcSEcCtD
Methysergide—HTR1E—head—brain cancer	0.00328	0.00512	CbGeAlD
Methysergide—HTR2A—ganglion—brain cancer	0.0031	0.00485	CbGeAlD
Methysergide—Flushing—Procarbazine—brain cancer	0.00307	0.00959	CcSEcCtD
Methysergide—HTR1E—central nervous system—brain cancer	0.00299	0.00467	CbGeAlD
Methysergide—Neutropenia—Hydroxyurea—brain cancer	0.00299	0.00934	CcSEcCtD
Methysergide—Dysuria—Hydroxyurea—brain cancer	0.00299	0.00934	CcSEcCtD
Methysergide—Body temperature increased—Lomustine—brain cancer	0.00292	0.00914	CcSEcCtD
Methysergide—Alopecia—Procarbazine—brain cancer	0.00292	0.00913	CcSEcCtD
Methysergide—Weight increased—Hydroxyurea—brain cancer	0.00291	0.00909	CcSEcCtD
Methysergide—Drowsiness—Hydroxyurea—brain cancer	0.00285	0.00891	CcSEcCtD
Methysergide—Ataxia—Carmustine—brain cancer	0.00281	0.00878	CcSEcCtD
Methysergide—HTR1B—brainstem—brain cancer	0.0028	0.00438	CbGeAlD
Methysergide—HTR1F—brain—brain cancer	0.00274	0.00428	CbGeAlD
Methysergide—Ataxia—Temozolomide—brain cancer	0.00272	0.00849	CcSEcCtD
Methysergide—HTR1D—brainstem—brain cancer	0.00271	0.00424	CbGeAlD
Methysergide—HTR2C—brainstem—brain cancer	0.00269	0.0042	CbGeAlD
Methysergide—HTR2A—endothelium—brain cancer	0.00267	0.00418	CbGeAlD
Methysergide—HTR6—head—brain cancer	0.00257	0.00402	CbGeAlD
Methysergide—Convulsion—Procarbazine—brain cancer	0.00249	0.00779	CcSEcCtD
Methysergide—HTR1B—telencephalon—brain cancer	0.00249	0.00389	CbGeAlD
Methysergide—HTR2A—blood vessel—brain cancer	0.00247	0.00385	CbGeAlD
Methysergide—Arthralgia—Procarbazine—brain cancer	0.00245	0.00766	CcSEcCtD
Methysergide—Myalgia—Procarbazine—brain cancer	0.00245	0.00766	CcSEcCtD
Methysergide—Neutropenia—Carmustine—brain cancer	0.00242	0.00755	CcSEcCtD
Methysergide—HTR1D—telencephalon—brain cancer	0.00241	0.00376	CbGeAlD
Methysergide—HTR2C—telencephalon—brain cancer	0.00239	0.00373	CbGeAlD
Methysergide—HTR1E—brain—brain cancer	0.00237	0.00371	CbGeAlD
Methysergide—HTR2A—hindbrain—brain cancer	0.00235	0.00368	CbGeAlD
Methysergide—Vomiting—Lomustine—brain cancer	0.00235	0.00735	CcSEcCtD
Methysergide—Oedema—Procarbazine—brain cancer	0.00235	0.00734	CcSEcCtD
Methysergide—HTR6—central nervous system—brain cancer	0.00235	0.00367	CbGeAlD
Methysergide—Dysuria—Temozolomide—brain cancer	0.00233	0.0073	CcSEcCtD
Methysergide—Neutropenia—Temozolomide—brain cancer	0.00233	0.0073	CcSEcCtD
Methysergide—Thrombocytopenia—Procarbazine—brain cancer	0.0023	0.00719	CcSEcCtD
Methysergide—Tachycardia—Procarbazine—brain cancer	0.00229	0.00716	CcSEcCtD
Methysergide—Weight increased—Temozolomide—brain cancer	0.00227	0.0071	CcSEcCtD
Methysergide—HTR1A—brainstem—brain cancer	0.00226	0.00354	CbGeAlD
Methysergide—Alopecia—Hydroxyurea—brain cancer	0.00226	0.00706	CcSEcCtD
Methysergide—Weight decreased—Temozolomide—brain cancer	0.00226	0.00706	CcSEcCtD
Methysergide—SIGMAR1—telencephalon—brain cancer	0.00225	0.00351	CbGeAlD
Methysergide—HTR2B—telencephalon—brain cancer	0.00224	0.0035	CbGeAlD
Methysergide—Nausea—Lomustine—brain cancer	0.0022	0.00687	CcSEcCtD
Methysergide—HTR7—brainstem—brain cancer	0.00216	0.00338	CbGeAlD
Methysergide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00214	0.00669	CcSEcCtD
Methysergide—Insomnia—Procarbazine—brain cancer	0.00212	0.00664	CcSEcCtD
Methysergide—Paraesthesia—Procarbazine—brain cancer	0.00211	0.00659	CcSEcCtD
Methysergide—Somnolence—Procarbazine—brain cancer	0.00209	0.00652	CcSEcCtD
Methysergide—Ill-defined disorder—Hydroxyurea—brain cancer	0.00207	0.00646	CcSEcCtD
Methysergide—Oedema peripheral—Carmustine—brain cancer	0.00204	0.00637	CcSEcCtD
Methysergide—Fatigue—Procarbazine—brain cancer	0.00202	0.00633	CcSEcCtD
Methysergide—HTR1A—telencephalon—brain cancer	0.00201	0.00314	CbGeAlD
Methysergide—Malaise—Hydroxyurea—brain cancer	0.00201	0.00628	CcSEcCtD
Methysergide—Constipation—Procarbazine—brain cancer	0.00201	0.00628	CcSEcCtD
Methysergide—Pain—Procarbazine—brain cancer	0.00201	0.00628	CcSEcCtD
Methysergide—Oedema peripheral—Temozolomide—brain cancer	0.00197	0.00615	CcSEcCtD
Methysergide—Feeling abnormal—Procarbazine—brain cancer	0.00193	0.00605	CcSEcCtD
Methysergide—Convulsion—Hydroxyurea—brain cancer	0.00193	0.00603	CcSEcCtD
Methysergide—Gastrointestinal pain—Procarbazine—brain cancer	0.00192	0.006	CcSEcCtD
Methysergide—HTR7—telencephalon—brain cancer	0.00192	0.003	CbGeAlD
Methysergide—Flushing—Carmustine—brain cancer	0.00192	0.006	CcSEcCtD
Methysergide—HTR2C—medulla oblongata—brain cancer	0.00187	0.00293	CbGeAlD
Methysergide—Discomfort—Hydroxyurea—brain cancer	0.00187	0.00585	CcSEcCtD
Methysergide—Neutropenia—Etoposide—brain cancer	0.00187	0.00584	CcSEcCtD
Methysergide—HTR6—brain—brain cancer	0.00186	0.00291	CbGeAlD
Methysergide—Abdominal pain—Procarbazine—brain cancer	0.00186	0.0058	CcSEcCtD
Methysergide—Body temperature increased—Procarbazine—brain cancer	0.00186	0.0058	CcSEcCtD
Methysergide—Flushing—Temozolomide—brain cancer	0.00185	0.0058	CcSEcCtD
Methysergide—SIGMAR1—pituitary gland—brain cancer	0.00183	0.00286	CbGeAlD
Methysergide—Alopecia—Carmustine—brain cancer	0.00183	0.00571	CcSEcCtD
Methysergide—Oedema—Hydroxyurea—brain cancer	0.00182	0.00568	CcSEcCtD
Methysergide—HTR1B—midbrain—brain cancer	0.00179	0.00279	CbGeAlD
Methysergide—Thrombocytopenia—Hydroxyurea—brain cancer	0.00178	0.00556	CcSEcCtD
Methysergide—Alopecia—Temozolomide—brain cancer	0.00177	0.00552	CcSEcCtD
Methysergide—SIGMAR1—medulla oblongata—brain cancer	0.00176	0.00276	CbGeAlD
Methysergide—HTR1B—spinal cord—brain cancer	0.00174	0.00272	CbGeAlD
Methysergide—Back pain—Carmustine—brain cancer	0.00174	0.00544	CcSEcCtD
Methysergide—HTR1D—midbrain—brain cancer	0.00173	0.0027	CbGeAlD
Methysergide—HTR2C—midbrain—brain cancer	0.00171	0.00268	CbGeAlD
Methysergide—Asthenia—Procarbazine—brain cancer	0.00168	0.00527	CcSEcCtD
Methysergide—Back pain—Temozolomide—brain cancer	0.00168	0.00526	CcSEcCtD
Methysergide—HTR2C—spinal cord—brain cancer	0.00167	0.00261	CbGeAlD
Methysergide—Dyspnoea—Hydroxyurea—brain cancer	0.00162	0.00506	CcSEcCtD
Methysergide—Somnolence—Hydroxyurea—brain cancer	0.00162	0.00505	CcSEcCtD
Methysergide—Ill-defined disorder—Temozolomide—brain cancer	0.00161	0.00504	CcSEcCtD
Methysergide—SIGMAR1—midbrain—brain cancer	0.00161	0.00252	CbGeAlD
Methysergide—Diarrhoea—Procarbazine—brain cancer	0.00161	0.00502	CcSEcCtD
Methysergide—HTR7—gonad—brain cancer	0.0016	0.0025	CbGeAlD
Methysergide—Dyspepsia—Hydroxyurea—brain cancer	0.0016	0.005	CcSEcCtD
Methysergide—SIGMAR1—spinal cord—brain cancer	0.00157	0.00246	CbGeAlD
Methysergide—HTR1B—endocrine gland—brain cancer	0.00157	0.00245	CbGeAlD
Methysergide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00157	0.0049	CcSEcCtD
Methysergide—Malaise—Temozolomide—brain cancer	0.00157	0.0049	CcSEcCtD
Methysergide—Fatigue—Hydroxyurea—brain cancer	0.00157	0.0049	CcSEcCtD
Methysergide—Convulsion—Carmustine—brain cancer	0.00156	0.00487	CcSEcCtD
Methysergide—Constipation—Hydroxyurea—brain cancer	0.00155	0.00486	CcSEcCtD
Methysergide—Pain—Hydroxyurea—brain cancer	0.00155	0.00486	CcSEcCtD
Methysergide—Dizziness—Procarbazine—brain cancer	0.00155	0.00485	CcSEcCtD
Methysergide—HTR1B—head—brain cancer	0.00155	0.00242	CbGeAlD
Methysergide—Chest pain—Carmustine—brain cancer	0.00153	0.00479	CcSEcCtD
Methysergide—Myalgia—Carmustine—brain cancer	0.00153	0.00479	CcSEcCtD
Methysergide—HTR7—medulla oblongata—brain cancer	0.00151	0.00236	CbGeAlD
Methysergide—Convulsion—Temozolomide—brain cancer	0.00151	0.00471	CcSEcCtD
Methysergide—HTR1D—head—brain cancer	0.0015	0.00234	CbGeAlD
Methysergide—Feeling abnormal—Hydroxyurea—brain cancer	0.0015	0.00468	CcSEcCtD
Methysergide—Vomiting—Procarbazine—brain cancer	0.00149	0.00467	CcSEcCtD
Methysergide—HTR2C—head—brain cancer	0.00149	0.00232	CbGeAlD
Methysergide—Flushing—Etoposide—brain cancer	0.00148	0.00464	CcSEcCtD
Methysergide—Arthralgia—Temozolomide—brain cancer	0.00148	0.00463	CcSEcCtD
Methysergide—Myalgia—Temozolomide—brain cancer	0.00148	0.00463	CcSEcCtD
Methysergide—Rash—Procarbazine—brain cancer	0.00148	0.00463	CcSEcCtD
Methysergide—Dermatitis—Procarbazine—brain cancer	0.00148	0.00462	CcSEcCtD
Methysergide—Oedema—Carmustine—brain cancer	0.00147	0.00459	CcSEcCtD
Methysergide—Discomfort—Temozolomide—brain cancer	0.00146	0.00457	CcSEcCtD
Methysergide—HTR1A—midbrain—brain cancer	0.00144	0.00225	CbGeAlD
Methysergide—Thrombocytopenia—Carmustine—brain cancer	0.00144	0.0045	CcSEcCtD
Methysergide—Body temperature increased—Hydroxyurea—brain cancer	0.00144	0.00449	CcSEcCtD
Methysergide—Tachycardia—Carmustine—brain cancer	0.00143	0.00448	CcSEcCtD
Methysergide—Oedema—Temozolomide—brain cancer	0.00142	0.00444	CcSEcCtD
Methysergide—HTR1B—central nervous system—brain cancer	0.00141	0.00221	CbGeAlD
Methysergide—Alopecia—Etoposide—brain cancer	0.00141	0.00442	CcSEcCtD
Methysergide—HTR1A—spinal cord—brain cancer	0.00141	0.0022	CbGeAlD
Methysergide—HTR2B—head—brain cancer	0.0014	0.00218	CbGeAlD
Methysergide—Nausea—Procarbazine—brain cancer	0.00139	0.00436	CcSEcCtD
Methysergide—Thrombocytopenia—Temozolomide—brain cancer	0.00139	0.00434	CcSEcCtD
Methysergide—HTR7—midbrain—brain cancer	0.00138	0.00215	CbGeAlD
Methysergide—HTR1D—central nervous system—brain cancer	0.00137	0.00214	CbGeAlD
Methysergide—HTR2C—central nervous system—brain cancer	0.00136	0.00212	CbGeAlD
Methysergide—HTR2A—brainstem—brain cancer	0.00135	0.00211	CbGeAlD
Methysergide—Back pain—Etoposide—brain cancer	0.00135	0.00421	CcSEcCtD
Methysergide—HTR7—spinal cord—brain cancer	0.00134	0.0021	CbGeAlD
Methysergide—Musculoskeletal discomfort—Carmustine—brain cancer	0.00134	0.00418	CcSEcCtD
Methysergide—Insomnia—Carmustine—brain cancer	0.00133	0.00415	CcSEcCtD
Methysergide—Paraesthesia—Carmustine—brain cancer	0.00132	0.00412	CcSEcCtD
Methysergide—Dyspnoea—Carmustine—brain cancer	0.00131	0.00409	CcSEcCtD
Methysergide—Somnolence—Carmustine—brain cancer	0.00131	0.00408	CcSEcCtD
Methysergide—Asthenia—Hydroxyurea—brain cancer	0.0013	0.00408	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00129	0.00404	CcSEcCtD
Methysergide—Ill-defined disorder—Etoposide—brain cancer	0.00129	0.00404	CcSEcCtD
Methysergide—Insomnia—Temozolomide—brain cancer	0.00128	0.00401	CcSEcCtD
Methysergide—Paraesthesia—Temozolomide—brain cancer	0.00127	0.00398	CcSEcCtD
Methysergide—HTR2B—central nervous system—brain cancer	0.00127	0.00199	CbGeAlD
Methysergide—Gastrointestinal disorder—Carmustine—brain cancer	0.00127	0.00396	CcSEcCtD
Methysergide—HTR1A—endocrine gland—brain cancer	0.00127	0.00198	CbGeAlD
Methysergide—Dyspnoea—Temozolomide—brain cancer	0.00127	0.00396	CcSEcCtD
Methysergide—Somnolence—Temozolomide—brain cancer	0.00126	0.00394	CcSEcCtD
Methysergide—Pain—Carmustine—brain cancer	0.00126	0.00393	CcSEcCtD
Methysergide—Constipation—Carmustine—brain cancer	0.00126	0.00393	CcSEcCtD
Methysergide—Malaise—Etoposide—brain cancer	0.00126	0.00392	CcSEcCtD
Methysergide—HTR1A—head—brain cancer	0.00125	0.00195	CbGeAlD
Methysergide—Dyspepsia—Temozolomide—brain cancer	0.00125	0.00391	CcSEcCtD
Methysergide—SIGMAR1—cerebellum—brain cancer	0.00125	0.00195	CbGeAlD
Methysergide—Diarrhoea—Hydroxyurea—brain cancer	0.00124	0.00389	CcSEcCtD
Methysergide—Gastrointestinal disorder—Temozolomide—brain cancer	0.00123	0.00383	CcSEcCtD
Methysergide—Fatigue—Temozolomide—brain cancer	0.00122	0.00383	CcSEcCtD
Methysergide—Constipation—Temozolomide—brain cancer	0.00121	0.00379	CcSEcCtD
Methysergide—Pain—Temozolomide—brain cancer	0.00121	0.00379	CcSEcCtD
Methysergide—Feeling abnormal—Carmustine—brain cancer	0.00121	0.00378	CcSEcCtD
Methysergide—HTR7—endocrine gland—brain cancer	0.00121	0.00189	CbGeAlD
Methysergide—Convulsion—Etoposide—brain cancer	0.00121	0.00377	CcSEcCtD
Methysergide—Dizziness—Hydroxyurea—brain cancer	0.0012	0.00376	CcSEcCtD
Methysergide—Gastrointestinal pain—Carmustine—brain cancer	0.0012	0.00375	CcSEcCtD
Methysergide—HTR2A—telencephalon—brain cancer	0.0012	0.00187	CbGeAlD
Methysergide—HTR7—head—brain cancer	0.00119	0.00187	CbGeAlD
Methysergide—Chest pain—Etoposide—brain cancer	0.00118	0.0037	CcSEcCtD
Methysergide—Discomfort—Etoposide—brain cancer	0.00117	0.00366	CcSEcCtD
Methysergide—Feeling abnormal—Temozolomide—brain cancer	0.00117	0.00366	CcSEcCtD
Methysergide—Body temperature increased—Carmustine—brain cancer	0.00116	0.00363	CcSEcCtD
Methysergide—Abdominal pain—Carmustine—brain cancer	0.00116	0.00363	CcSEcCtD
Methysergide—Gastrointestinal pain—Temozolomide—brain cancer	0.00116	0.00363	CcSEcCtD
Methysergide—Vomiting—Hydroxyurea—brain cancer	0.00116	0.00361	CcSEcCtD
Methysergide—Rash—Hydroxyurea—brain cancer	0.00115	0.00358	CcSEcCtD
Methysergide—Dermatitis—Hydroxyurea—brain cancer	0.00114	0.00358	CcSEcCtD
Methysergide—HTR1A—central nervous system—brain cancer	0.00114	0.00178	CbGeAlD
Methysergide—HTR1B—brain—brain cancer	0.00112	0.00175	CbGeAlD
Methysergide—Body temperature increased—Temozolomide—brain cancer	0.00112	0.00351	CcSEcCtD
Methysergide—Abdominal pain—Temozolomide—brain cancer	0.00112	0.00351	CcSEcCtD
Methysergide—HTR1A—cerebellum—brain cancer	0.00112	0.00174	CbGeAlD
Methysergide—Thrombocytopenia—Etoposide—brain cancer	0.00111	0.00348	CcSEcCtD
Methysergide—Tachycardia—Etoposide—brain cancer	0.00111	0.00347	CcSEcCtD
Methysergide—HTR7—central nervous system—brain cancer	0.00109	0.0017	CbGeAlD
Methysergide—HTR1D—brain—brain cancer	0.00109	0.0017	CbGeAlD
Methysergide—Nausea—Hydroxyurea—brain cancer	0.00108	0.00337	CcSEcCtD
Methysergide—HTR2C—brain—brain cancer	0.00108	0.00168	CbGeAlD
Methysergide—HTR7—cerebellum—brain cancer	0.00107	0.00167	CbGeAlD
Methysergide—Asthenia—Carmustine—brain cancer	0.00105	0.00329	CcSEcCtD
Methysergide—Paraesthesia—Etoposide—brain cancer	0.00102	0.00319	CcSEcCtD
Methysergide—Asthenia—Temozolomide—brain cancer	0.00102	0.00318	CcSEcCtD
Methysergide—SIGMAR1—brain—brain cancer	0.00101	0.00158	CbGeAlD
Methysergide—Dyspnoea—Etoposide—brain cancer	0.00101	0.00317	CcSEcCtD
Methysergide—HTR2B—brain—brain cancer	0.00101	0.00158	CbGeAlD
Methysergide—Somnolence—Etoposide—brain cancer	0.00101	0.00316	CcSEcCtD
Methysergide—Diarrhoea—Carmustine—brain cancer	0.00101	0.00314	CcSEcCtD
Methysergide—HTR2A—gonad—brain cancer	0.000999	0.00156	CbGeAlD
Methysergide—Gastrointestinal disorder—Etoposide—brain cancer	0.000981	0.00307	CcSEcCtD
Methysergide—Fatigue—Etoposide—brain cancer	0.000979	0.00306	CcSEcCtD
Methysergide—HTR2A—pituitary gland—brain cancer	0.000974	0.00152	CbGeAlD
Methysergide—Dizziness—Carmustine—brain cancer	0.000971	0.00304	CcSEcCtD
Methysergide—Pain—Etoposide—brain cancer	0.000971	0.00304	CcSEcCtD
Methysergide—Constipation—Etoposide—brain cancer	0.000971	0.00304	CcSEcCtD
Methysergide—Diarrhoea—Temozolomide—brain cancer	0.000971	0.00304	CcSEcCtD
Methysergide—HTR2A—medulla oblongata—brain cancer	0.00094	0.00147	CbGeAlD
Methysergide—Dizziness—Temozolomide—brain cancer	0.000939	0.00293	CcSEcCtD
Methysergide—Feeling abnormal—Etoposide—brain cancer	0.000936	0.00293	CcSEcCtD
Methysergide—Vomiting—Carmustine—brain cancer	0.000934	0.00292	CcSEcCtD
Methysergide—Gastrointestinal pain—Etoposide—brain cancer	0.000929	0.0029	CcSEcCtD
Methysergide—Rash—Carmustine—brain cancer	0.000926	0.0029	CcSEcCtD
Methysergide—Dermatitis—Carmustine—brain cancer	0.000925	0.00289	CcSEcCtD
Methysergide—HTR1A—brain—brain cancer	0.000906	0.00142	CbGeAlD
Methysergide—Vomiting—Temozolomide—brain cancer	0.000903	0.00282	CcSEcCtD
Methysergide—Body temperature increased—Etoposide—brain cancer	0.000898	0.00281	CcSEcCtD
Methysergide—Abdominal pain—Etoposide—brain cancer	0.000898	0.00281	CcSEcCtD
Methysergide—Rash—Temozolomide—brain cancer	0.000895	0.0028	CcSEcCtD
Methysergide—Dermatitis—Temozolomide—brain cancer	0.000894	0.0028	CcSEcCtD
Methysergide—Nausea—Carmustine—brain cancer	0.000873	0.00273	CcSEcCtD
Methysergide—HTR7—brain—brain cancer	0.000866	0.00135	CbGeAlD
Methysergide—HTR2A—midbrain—brain cancer	0.000859	0.00134	CbGeAlD
Methysergide—Nausea—Temozolomide—brain cancer	0.000843	0.00264	CcSEcCtD
Methysergide—HTR2A—spinal cord—brain cancer	0.000838	0.00131	CbGeAlD
Methysergide—Asthenia—Etoposide—brain cancer	0.000815	0.00255	CcSEcCtD
Methysergide—Diarrhoea—Etoposide—brain cancer	0.000777	0.00243	CcSEcCtD
Methysergide—HTR2A—endocrine gland—brain cancer	0.000755	0.00118	CbGeAlD
Methysergide—Dizziness—Etoposide—brain cancer	0.000751	0.00235	CcSEcCtD
Methysergide—HTR2A—head—brain cancer	0.000745	0.00116	CbGeAlD
Methysergide—Vomiting—Etoposide—brain cancer	0.000722	0.00226	CcSEcCtD
Methysergide—Rash—Etoposide—brain cancer	0.000716	0.00224	CcSEcCtD
Methysergide—Dermatitis—Etoposide—brain cancer	0.000716	0.00224	CcSEcCtD
Methysergide—HTR2A—central nervous system—brain cancer	0.00068	0.00106	CbGeAlD
Methysergide—Nausea—Etoposide—brain cancer	0.000675	0.00211	CcSEcCtD
Methysergide—HTR2A—cerebellum—brain cancer	0.000665	0.00104	CbGeAlD
Methysergide—HTR2A—brain—brain cancer	0.00054	0.000844	CbGeAlD
Methysergide—HTR1B—Signaling Pathways—SMO—brain cancer	3.34e-05	0.000834	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PDGFRA—brain cancer	3.33e-05	0.000831	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SHH—brain cancer	3.31e-05	0.000826	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HES1—brain cancer	3.3e-05	0.000824	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—VAV1—brain cancer	3.28e-05	0.00082	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—VAV1—brain cancer	3.26e-05	0.000815	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SPP1—brain cancer	3.23e-05	0.000807	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HEY1—brain cancer	3.22e-05	0.000804	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GLI1—brain cancer	3.21e-05	0.000801	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HEY1—brain cancer	3.2e-05	0.0008	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—IL2—brain cancer	3.19e-05	0.000798	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TRPC6—brain cancer	3.19e-05	0.000797	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DLL1—brain cancer	3.16e-05	0.000788	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PDGFRA—brain cancer	3.14e-05	0.000784	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DLL1—brain cancer	3.14e-05	0.000784	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PTCH1—brain cancer	3.14e-05	0.000783	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SMO—brain cancer	3.14e-05	0.000783	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—VAV1—brain cancer	3.12e-05	0.00078	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—PIK3CG—brain cancer	3.1e-05	0.000774	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—PIK3CG—brain cancer	3.1e-05	0.000773	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—PIK3CG—brain cancer	3.08e-05	0.000768	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL2—brain cancer	3.07e-05	0.000768	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SPP1—brain cancer	3.05e-05	0.000761	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SUFU—brain cancer	3.04e-05	0.000759	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—PIK3CG—brain cancer	3.01e-05	0.000752	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GFAP—brain cancer	2.93e-05	0.000732	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IRS2—brain cancer	2.92e-05	0.00073	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL2—brain cancer	2.9e-05	0.000724	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—VAV1—brain cancer	2.84e-05	0.000708	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—PIK3CG—brain cancer	2.83e-05	0.000707	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—PIK3CG—brain cancer	2.82e-05	0.000703	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—PIK3CG—brain cancer	2.81e-05	0.000702	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—PIK3CG—brain cancer	2.79e-05	0.000698	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HEY1—brain cancer	2.78e-05	0.000694	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IRS2—brain cancer	2.76e-05	0.000688	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NOTCH2—brain cancer	2.75e-05	0.000686	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NOTCH2—brain cancer	2.74e-05	0.000685	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—PIK3CG—brain cancer	2.74e-05	0.000683	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DLL1—brain cancer	2.73e-05	0.000681	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOTCH2—brain cancer	2.73e-05	0.000681	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SHH—brain cancer	2.68e-05	0.00067	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOTCH2—brain cancer	2.67e-05	0.000667	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SHH—brain cancer	2.67e-05	0.000667	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VAV1—brain cancer	2.62e-05	0.000654	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VAV1—brain cancer	2.62e-05	0.000653	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VAV1—brain cancer	2.6e-05	0.000649	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TRPC6—brain cancer	2.59e-05	0.000646	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—APC—brain cancer	2.58e-05	0.000645	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PIK3CG—brain cancer	2.58e-05	0.000645	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TRPC6—brain cancer	2.57e-05	0.000643	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	2.57e-05	0.000642	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VAV1—brain cancer	2.54e-05	0.000636	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SMO—brain cancer	2.54e-05	0.000635	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTCH1—brain cancer	2.54e-05	0.000635	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SMO—brain cancer	2.53e-05	0.000632	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTCH1—brain cancer	2.53e-05	0.000632	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOTCH2—brain cancer	2.51e-05	0.000626	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PIK3CG—brain cancer	2.43e-05	0.000608	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—APC—brain cancer	2.43e-05	0.000608	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VAV1—brain cancer	2.39e-05	0.000597	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—EGFR—brain cancer	2.35e-05	0.000587	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SHH—brain cancer	2.32e-05	0.000579	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	2.29e-05	0.000573	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	2.28e-05	0.00057	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HES1—brain cancer	2.25e-05	0.000563	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HES1—brain cancer	2.25e-05	0.000562	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HES1—brain cancer	2.24e-05	0.000558	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TRPC6—brain cancer	2.24e-05	0.000558	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—EGFR—brain cancer	2.22e-05	0.000554	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SMO—brain cancer	2.2e-05	0.000549	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTCH1—brain cancer	2.2e-05	0.000549	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HES1—brain cancer	2.19e-05	0.000547	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—IL2—brain cancer	2.18e-05	0.000545	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—IL2—brain cancer	2.18e-05	0.000544	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—IL2—brain cancer	2.16e-05	0.000541	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PDGFRA—brain cancer	2.14e-05	0.000536	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PDGFRA—brain cancer	2.14e-05	0.000535	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PDGFRA—brain cancer	2.13e-05	0.000532	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—IL2—brain cancer	2.12e-05	0.000529	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PDGFRA—brain cancer	2.08e-05	0.000521	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	2.08e-05	0.00052	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SPP1—brain cancer	2.08e-05	0.00052	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SPP1—brain cancer	2.08e-05	0.000519	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	2.07e-05	0.000518	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SPP1—brain cancer	2.07e-05	0.000516	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HES1—brain cancer	2.06e-05	0.000514	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOTCH2—brain cancer	2.03e-05	0.000508	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SPP1—brain cancer	2.02e-05	0.000505	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOTCH2—brain cancer	2.02e-05	0.000505	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—RELA—brain cancer	2.02e-05	0.000504	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—ERBB2—brain cancer	2e-05	0.0005	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.99e-05	0.000497	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.98e-05	0.000495	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL2—brain cancer	1.98e-05	0.000495	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL2—brain cancer	1.98e-05	0.000494	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL2—brain cancer	1.97e-05	0.000491	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.96e-05	0.000489	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VAV1—brain cancer	1.94e-05	0.000484	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VAV1—brain cancer	1.93e-05	0.000482	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL2—brain cancer	1.92e-05	0.000481	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—RELA—brain cancer	1.9e-05	0.000475	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SPP1—brain cancer	1.9e-05	0.000475	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ERBB2—brain cancer	1.89e-05	0.000472	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IRS2—brain cancer	1.88e-05	0.00047	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IRS2—brain cancer	1.88e-05	0.00047	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IRS2—brain cancer	1.87e-05	0.000467	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IRS2—brain cancer	1.83e-05	0.000457	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL2—brain cancer	1.82e-05	0.000454	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL2—brain cancer	1.81e-05	0.000452	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.8e-05	0.00045	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCND1—brain cancer	1.77e-05	0.000442	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.76e-05	0.000439	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CTNNB1—brain cancer	1.75e-05	0.000438	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IRS2—brain cancer	1.72e-05	0.000429	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL2—brain cancer	1.71e-05	0.000428	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VAV1—brain cancer	1.67e-05	0.000418	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCND1—brain cancer	1.67e-05	0.000417	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HES1—brain cancer	1.67e-05	0.000416	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—APC—brain cancer	1.66e-05	0.000415	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PIK3CG—brain cancer	1.66e-05	0.000415	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—APC—brain cancer	1.66e-05	0.000415	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PIK3CG—brain cancer	1.66e-05	0.000415	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HES1—brain cancer	1.66e-05	0.000414	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CTNNB1—brain cancer	1.65e-05	0.000413	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—APC—brain cancer	1.65e-05	0.000412	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3CG—brain cancer	1.65e-05	0.000412	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—APC—brain cancer	1.62e-05	0.000404	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3CG—brain cancer	1.62e-05	0.000404	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.61e-05	0.000403	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.61e-05	0.000401	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.59e-05	0.000397	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.58e-05	0.000394	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—VEGFA—brain cancer	1.54e-05	0.000385	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SPP1—brain cancer	1.54e-05	0.000385	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SPP1—brain cancer	1.53e-05	0.000383	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—STAT3—brain cancer	1.53e-05	0.000382	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—APC—brain cancer	1.52e-05	0.000379	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.52e-05	0.000379	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—EGFR—brain cancer	1.52e-05	0.000378	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—EGFR—brain cancer	1.51e-05	0.000378	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—EGFR—brain cancer	1.5e-05	0.000376	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—EGFR—brain cancer	1.47e-05	0.000368	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL2—brain cancer	1.47e-05	0.000366	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL2—brain cancer	1.46e-05	0.000364	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—VEGFA—brain cancer	1.46e-05	0.000364	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—STAT3—brain cancer	1.44e-05	0.00036	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HES1—brain cancer	1.44e-05	0.00036	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MYC—brain cancer	1.42e-05	0.000355	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.4e-05	0.000348	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IRS2—brain cancer	1.39e-05	0.000348	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EGFR—brain cancer	1.39e-05	0.000347	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IRS2—brain cancer	1.39e-05	0.000346	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—EGFR—brain cancer	1.38e-05	0.000345	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.37e-05	0.000343	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MYC—brain cancer	1.34e-05	0.000335	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SPP1—brain cancer	1.33e-05	0.000333	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EGFR—brain cancer	1.31e-05	0.000327	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—RELA—brain cancer	1.3e-05	0.000325	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—RELA—brain cancer	1.3e-05	0.000324	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ERBB2—brain cancer	1.29e-05	0.000322	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ERBB2—brain cancer	1.29e-05	0.000322	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—RELA—brain cancer	1.29e-05	0.000322	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.28e-05	0.00032	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL2—brain cancer	1.27e-05	0.000316	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—RELA—brain cancer	1.26e-05	0.000315	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ERBB2—brain cancer	1.25e-05	0.000313	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APC—brain cancer	1.23e-05	0.000307	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.23e-05	0.000307	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APC—brain cancer	1.22e-05	0.000306	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.22e-05	0.000306	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IRS2—brain cancer	1.2e-05	0.000301	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—RELA—brain cancer	1.19e-05	0.000296	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.18e-05	0.000294	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL2—brain cancer	1.17e-05	0.000292	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL2—brain cancer	1.17e-05	0.000292	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TP53—brain cancer	1.17e-05	0.000291	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL2—brain cancer	1.16e-05	0.00029	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCND1—brain cancer	1.14e-05	0.000285	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCND1—brain cancer	1.14e-05	0.000285	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL2—brain cancer	1.14e-05	0.000284	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCND1—brain cancer	1.13e-05	0.000283	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.13e-05	0.000282	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.13e-05	0.000282	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.12e-05	0.00028	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.12e-05	0.00028	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.12e-05	0.000279	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCND1—brain cancer	1.11e-05	0.000277	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TP53—brain cancer	1.1e-05	0.000275	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.1e-05	0.000274	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL2—brain cancer	1.07e-05	0.000267	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APC—brain cancer	1.06e-05	0.000266	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.06e-05	0.000266	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCND1—brain cancer	1.04e-05	0.00026	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CTNNB1—brain cancer	1.03e-05	0.000258	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VEGFA—brain cancer	9.95e-06	0.000248	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VEGFA—brain cancer	9.93e-06	0.000248	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VEGFA—brain cancer	9.87e-06	0.000247	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—STAT3—brain cancer	9.85e-06	0.000246	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—STAT3—brain cancer	9.84e-06	0.000246	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—STAT3—brain cancer	9.77e-06	0.000244	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EGFR—brain cancer	9.69e-06	0.000242	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VEGFA—brain cancer	9.66e-06	0.000241	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—RELA—brain cancer	9.62e-06	0.00024	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RELA—brain cancer	9.57e-06	0.000239	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—STAT3—brain cancer	9.57e-06	0.000239	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ERBB2—brain cancer	9.56e-06	0.000239	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ERBB2—brain cancer	9.51e-06	0.000237	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MYC—brain cancer	9.15e-06	0.000229	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MYC—brain cancer	9.14e-06	0.000228	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MYC—brain cancer	9.08e-06	0.000227	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VEGFA—brain cancer	9.08e-06	0.000227	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—STAT3—brain cancer	8.99e-06	0.000225	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EGFR—brain cancer	8.95e-06	0.000224	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EGFR—brain cancer	8.94e-06	0.000223	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MYC—brain cancer	8.89e-06	0.000222	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EGFR—brain cancer	8.88e-06	0.000222	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EGFR—brain cancer	8.7e-06	0.000217	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL2—brain cancer	8.66e-06	0.000216	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL2—brain cancer	8.62e-06	0.000215	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCND1—brain cancer	8.44e-06	0.000211	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCND1—brain cancer	8.4e-06	0.00021	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CTNNB1—brain cancer	8.36e-06	0.000209	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MYC—brain cancer	8.35e-06	0.000209	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CTNNB1—brain cancer	8.32e-06	0.000208	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RELA—brain cancer	8.31e-06	0.000208	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ERBB2—brain cancer	8.26e-06	0.000206	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EGFR—brain cancer	8.17e-06	0.000204	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TP53—brain cancer	7.51e-06	0.000188	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TP53—brain cancer	7.51e-06	0.000187	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL2—brain cancer	7.48e-06	0.000187	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TP53—brain cancer	7.46e-06	0.000186	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VEGFA—brain cancer	7.36e-06	0.000184	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.32e-06	0.000183	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TP53—brain cancer	7.3e-06	0.000182	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCND1—brain cancer	7.3e-06	0.000182	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—STAT3—brain cancer	7.29e-06	0.000182	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—STAT3—brain cancer	7.25e-06	0.000181	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.22e-06	0.00018	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TP53—brain cancer	6.86e-06	0.000171	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MYC—brain cancer	6.77e-06	0.000169	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MYC—brain cancer	6.74e-06	0.000168	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EGFR—brain cancer	6.63e-06	0.000165	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EGFR—brain cancer	6.59e-06	0.000165	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.36e-06	0.000159	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—STAT3—brain cancer	6.3e-06	0.000157	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MYC—brain cancer	5.85e-06	0.000146	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EGFR—brain cancer	5.72e-06	0.000143	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TP53—brain cancer	5.56e-06	0.000139	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TP53—brain cancer	5.53e-06	0.000138	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TP53—brain cancer	4.81e-06	0.00012	CbGpPWpGaD
